Skip to main content
Filing year 2023

THE LEUKEMIA & LYMPHOMA SOCIETYINC

Washington, District of Columbia·EIN 13-5644916·NTEE G300 · Diseases, Disorders & Medical Disciplines·3
Total revenue
$368.2M
Total assets
$602M
Total expenses
$0
Reported officers
31
Mission

OUR MISSION IS TO CURE LEUKEMIA, LYMPHOMA, HODGKIN'S DISEASE AND MYELOMA, AND IMPROVE THE QUALITY OF LIFE OF PATIENTS AND THEIR FAMILIES.

Executive compensation, broken down

Form 990 · Schedule J · 11 reported individuals · Filing year 2023

Base salaryBonusOther compensationBenefits
Base salaryBonusOther compensationBenefitsExecutive compensation
President & CEO - Former
$1.4M
Evp, Chief Medical Ofc
executive vice president
$577k
Evp, Chief Operating Ofc
executive vice president
$560k
Evp, General Counsel
executive vice president
$528k
Evp, Chief Financial Ofc
executive vice president
$512k
$480k
Svp, Chief Dei Ofc
senior vice president
$430k
Svp, Chief Scientific Ofc
senior vice president
$422k
Svp, Chief Development Ofc
senior vice president
$420k
Svp, Chief Advancement Ofc
senior vice president
$416k
Svp, Chief Experience Ofc
senior vice president
$386k

Plus 20 unpaid individuals.

Browse compensation in Diseases, Disorders & Medical Disciplines

Up 49%
from 2022

From $931k in 2022 to $1.4M in 2023.

$931k
2022
$1.4M
2023
Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.